www.chinadaily.com.cn

Sinopharm puts three antibody COVID treatments into trial

Zhu Jingjin, deputy president of China National Biotec Group, China National Pharmaceutical Group's biotech subsidiary, said at a media conference in Beijing on Monday the company's three virus neutra